Anavex Life Sciences
AVXL
AVXL
149 hedge funds and large institutions have $249M invested in Anavex Life Sciences in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $310M → $249M (-$60.5M)
27% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $19.7M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
149
Holding in Top 10
–
Calls
$14.4M
Puts
$19.7M
Top Buyers
| 1 | +$4.72M | |
| 2 | +$3.79M | |
| 3 | +$3.58M | |
| 4 |
Millennium Management
New York
|
+$2.62M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.52M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$2.72M | |
| 3 | -$2.6M | |
| 4 |
Rafferty Asset Management
New York
|
-$2.01M |
| 5 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$1.75M |